Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT03994380
PHASE1/PHASE2

Use of DNAse in Neutrophilic Asthma

Sponsor: National Jewish Health

View on ClinicalTrials.gov

Summary

In this pilot protocol, the researchers look to determine benefits from use of nebulized rh-DNase for 4 weeks in patients with neutrophilic asthma.

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

19

Start Date

2020-02-12

Completion Date

2022-12-31

Last Updated

2026-04-20

Healthy Volunteers

No

Interventions

DRUG

RhDNAse Inhalation Solution

rhDNAse 2.5 mg nebulizer daily for 4 weeks

Locations (1)

National Jewish Health

Denver, Colorado, United States